July 26, 2016 4:19 PM ET

Biotechnology

Company Overview of Cellular Dynamics International, Inc.

Company Overview

Cellular Dynamics International, Inc. develops and manufactures human cells in the United States, Europe, Japan, and internationally. The company’s proprietary products include human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs), and custom iPSCs and iCell products (MyCell products). It offers iCell Cardiomyocytes, which are purified human heart cells that beat in a dish and behave just like the heart cells found in the human body for in vitro drug discovery, toxicity testing, and chemical safety, as well as in vivo cellular therapeutics research and development, and stem cell banking; and iCell Neurons that are purified human neurons typical of ...

525 Science Drive

Madison, WI 53711

United States

Founded in 2004

155 Employees

Phone:

608-310-5100

Key Executives for Cellular Dynamics International, Inc.

Chairman and Chief Executive Officer
President and Chief Operating Officer
Age: 47
Founder and Vice Chairman
Age: 63
Co-Founder, Chief Scientific Officer, Director and Member of Scientific Advisory Board
Age: 57
Co-Founder and Director
Age: 68
Compensation as of Fiscal Year 2016.

Cellular Dynamics International, Inc. Key Developments

Cellular Dynamics International, Inc. and National Eye Institute Sign Cooperative Research and Development Deal

Cellular Dynamics International has entered into a Cooperative Research and Development Agreement (CRADA) with the National Eye Institute (NEI) to conduct research to advance a cell transplantation therapy for the treatment of retinal degenerative disease using retinal pigment epithelium derived from induced pluripotent stem cells (iPSC-RPE). The collaboration includes the joint development of an optimized biocompatible biodegradable scaffold that is likely to be a critical component for a potential future therapy.

Cellular Dynamics and the National Eye Institute Establish a Cooperative Research and Development Agreement (CRADA) to Advance Cell Transplantation Therapy for the Treatment of Retinal Degenerative Disease Using iPSC-Derived Cells

Cellular Dynamics International, Inc. announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Eye Institute (NEI), a division of the National Institutes of Health (NIH), to conduct research to advance a cell transplantation therapy for the treatment of retinal degenerative disease using retinal pigment epithelium derived from induced pluripotent stem cells (iPSC-RPE). The collaboration includes the joint development of an optimized biocompatible biodegradable scaffold that is likely to be a critical component for a potential future therapy.

Cellular Dynamics International, Inc. Appoints Derek Hei as Vice President of Clinical Manufacture, Quality, and Regulatory Activities

Cellular Dynamics International, Inc. announced the appointment of Derek Hei, Ph.D., as Vice President of Clinical Manufacture, Quality, and Regulatory activities to lead efforts in support of manufacturing induced pluripotent stem cell (iPSC)-based products for cell therapies. Dr. Hei has over twenty years of experience developing biotherapeutics from research through clinical trials, most recently as director at Waisman Biomanufacturing. Dr. Hei will direct and manage cGMP-compliant manufacturing processes for production of differentiated and genetically modified cell therapies for clinical trials and cell banking; he will be principally responsible for establishing robust systems for quality control and process validation. At Waisman Biomanufacturing, Dr. Hei was responsible for establishing a biotherapeutics and cell therapy contract manufacturing facility from the design and construction stages through to management of all aspects of operations.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cellular Dynamics International, Inc., please visit www.cellulardynamics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.